Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women

G. Christodoulacos; Constantinos Panoulis; D. Botsis; Demetrios Rizos; Dimitrios Kassanos; George Creatsas

doi:10.1016/s0378-5122(02)00027-0

Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women

G. Christodoulacos, Constantinos Panoulis, D. Botsis, Demetrios Rizos, Dimitrios Kassanos, George Creatsas

In: Maturitas · 2002 · vol. 42(1) , pp. 77–84 · doi:10.1016/s0378-5122(02)00027-0 · PMID:12020983 · W2036755428

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This study used transvaginal sonography to monitor the uterine effects of raloxifene and a continuous combined hormone replacement therapy in postmenopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness 2005

References (24)

Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use via openalex
Transvaginal sonography of the endometrium in postmenopausal women: Monitoring the effect of hormone replacement therapy via openalex
doi:10.1016/0029-7844(94)00383-o via openalex
W125936910 via openalex
doi:10.1016/s0029-7844(98)00476-1 via openalex
doi:10.1016/s0002-9378(94)70129-6 via openalex
doi:10.1067/mob.2000.104768 via openalex
doi:10.1016/s0378-5122(98)00014-0 via openalex
doi:10.1097/00006254-199805000-00020 via openalex
doi:10.1016/s0378-5122(99)00007-9 via openalex
doi:10.1067/mob.2000.104767 via openalex
doi:10.1016/0378-5122(94)90015-9 via openalex
doi:10.1016/s0140-6736(94)92466-x via openalex
W2413558923 via openalex
W6715792074 via openalex
doi:10.1007/bf02383389 via openalex
doi:10.1016/s0029-7844(99)00502-5 via openalex
doi:10.1016/s0002-9378(98)70553-8 via openalex
doi:10.1016/s0378-5122(97)00037-6 via openalex
doi:10.1016/s0140-6736(96)07365-5 via openalex
doi:10.1016/0378-5122(96)01010-9 via openalex
doi:10.1016/0378-5122(96)00993-0 via openalex
doi:10.1016/s0002-9378(97)70091-7 via openalex
doi:10.1056/nejm199712043372301 via openalex

Cited by (1)

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness 2005

Source provenance

openalex: last seen: 2026-05-11T06:22:51.059792+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] Transvaginal sonography of the endometrium in postmenopausal women: Monitoring the effect of hormone replacement therapy 1994

[2] Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use 1996